DE COBELLI, OTTAVIO
DE COBELLI, OTTAVIO
Dipartimento di Oncologia ed Emato-Oncologia
"Burned out" phenomenon of the testis in retroperitoneal seminoma
2006 G. Curigliano , E. Magni , G. Renne , O. De Cobelli , M. Rescigno , R. Torrisi , G. Spitaleri , E. Pietri , F. De Braud , A. Goldhirsch
"Give me five" ultra-hypofractionated radiotherapy for localized prostate cancer: non-invasive ablative approach
2018 G. Marvaso, G. Riva, D. Ciardo, S. Gandini, C. Fodor, D. Zerini, S.P. Colangione, G. Timon, S. Comi, R. Cambria, F. Cattani, O. De Cobelli, R. Orecchia, B.A. Jereczek
"Saturation target biopsies" : can reduction of biopsy cores maintain accuracy of MPMRI supported targeted and systematic trans-perineal prostate biopsies?
2017 A. Macchi, T. Lloyd, M. Czarniecki, T. Barrett, O. De Cobelli, E. Montanari, C. Kastner
1076 Independent validation of the 2010 TNM staging system for renal cell carcinoma : does it improves predictive accuracy in cancer-specific mortality compared to 2002 TNM?
2013 M. Roscigno, S.F. Shariat, M. May, G. Novara, R. Zigeuner, L. Schips, O. De Cobelli, B. Rocco, C. De Nunzio, B. Feciche, M. Truss, S. Pahernik, M.P. Wirth, N. Longo, A. Simonato, S. Serni, S. Siracusano, A. Volpe, G. Morgia, G. Martorana, F. Montorsi, V. Ficarra, S. Brookman May
[11C]Choline PET/CT impacts treatment decision making in patients with prostate cancer referred for radiotherapy
2014 B.A. Jereczek-Fossa, M. Rodari, M. Bonora, P. Fanti, C. Fodor, G. Pepe, E. Lopci, D. Zerini, B. Vischioni, G. Baroni, D.V. Matei, O. De Cobelli, A. Chiti, R. Orecchia
A comprehensive evaluation of sexual and reproductive outcomes following robot-assisted retroperitoneal lymph node dissection for nonseminomatous germ cell tumor
2022 F.A. Mistretta, O. de Cobelli, P. Verze, F. Botticelli, L. Jannello, S. Luzzago, G. Cozzi, R. Bianchi, E. Di Trapani, M. Ferro, G. Cordima, D. Bottero, D.V. Matei, V. Mirone, G. Musi
A global Unified Dosimetry Index (gUDI) to evaluate simultaneous integrated boost radiotherapy plans in prostate cancer
2018 M. Mambretti, C. Romanò, G. Marvaso, S. Comi, R. Cambria, D. Ciardo, F. Emiro, C. Fodor, D. Zerini, G. Riva, G. Petralia, O. De Cobelli, R. Orecchia, F. Cattani, B.A. Jereczek
A guide for oncologic patient management during covid-19 pandemic: The initial experience of an Italian oncologic hub with exemplificative focus on uro-oncologic patients
2020 F.A. Mistretta, S. Luzzago, L.O. Molendini, M. Ferro, E. Dossena, F. Mastrilli, G. Musi, O. de Cobelli
A novel "intuitive" surgical technique for right robot-assisted retroperitoneal lymph node dissection for stage I testicular NSGCT
2013 O. de Cobelli, A. Brescia, F. Mazzoleni, G. Musi, D.V. Matei
A novel nomogram predicting lymph node invasion among patients with prostate cancer: The importance of extracapsular extension at multiparametric magnetic resonance imaging
2021 E. Di Trapani, S. Luzzago, G. Peveri, M. Catellani, M. Ferro, G. Cordima, F.A. Mistretta, R. Bianchi, G. Cozzi, S. Alessi, D.V. Matei, V. Bagnardi, G. Petralia, G. Musi, O. De Cobelli
A novel nomogram to identify candidates for active surveillance among patients with ISUP Grade Group 1 or ISUP Grade Group 2 prostate cancer, according to multiparametric magnetic resonance imaging findings
2020 S. Luzzago, O. de Cobelli, G. Cozzi, G. Peveri, V. Bagnardi, M. Catellani, E. Di Trapani, F.A. Mistretta, P. Pricolo, A. Conti, S. Alessi, G. Marvaso, M. Ferro, D. Matei, G. Renne, B. Jereczek-Fossa, G. Petralia, G. Musi
A randomized phase IIb presurgical study of finasteride vs. low-dose flutamide vs. placebo in men with prostate cancer. Efficacy monitored by karyometry
2013 R. Montironi, P.H. Bartels, A. Decensi, M. Puntoni, R. Hurle, O. De Cobelli, G. Carmignani, R. Mazzucchelli, H.G. Bartels, D.S. Alberts, M. Maffezzini
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy
2021 M. Ferro, G. Lucarelli, O. de Cobelli, P. Dolce, D. Terracciano, G. Musi, A. Porreca, G.M. Busetto, F. Del Giudice, F. Soria, P. Gontero, F. Cantiello, R. Damiano, F. Crocerossa, A.R. Abu Farhan, R. Autorino, M.D. Vartolomei, M. Marchioni, A. Mari, A. Minervini, N. Longo, G. Celentano, F. Chiancone, S. Perdonà, P. Del Prete, P. Ditonno, M. Battaglia, S. Zamboni, A. Antonelli, F. Greco, G.I. Russo, R. Hurle, N. Crisan, M. Manfredi, F. Porpiglia, D. Ribera, P. De Placido, S. Facchini, L. Scafuri, A. Verde, G. Di Lorenzo, V. Cosimato, A. Luciano, V.F. Caputo, F. Crocetto, C. Buonerba
Absence of epidermal growth factor receptor gene mutations in patients with hormone refractory prostate cancer not responding to gefitinib
2007 G. Curigliano, G. Pelosi, T. De Pas, G. Renne, O. De Cobelli, M. Manzotti, G. Spitaleri, F. de Braud
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette–Guérin after transurethral resection of the bladder tumor
2019 M. Ferro, G. Di Lorenzo, M.D. Vartolomei, D. Bruzzese, F. Cantiello, G. Lucarelli, G. Musi, S. Di Stasi, R. Hurle, G. Guazzoni, G.M. Busetto, A. Gabriele, F. Del Giudice, R. Damiano, F. Perri, S. Perdona, P. Verze, M. Borghesi, R. Schiavina, G.L. Almeida, P. Bove, E. Lima, R. Autorino, N. Crisan, A.R.A. Farhan, M. Battaglia, G.I. Russo, V. Ieluzzi, G. Morgia, P. De Placido, D. Terracciano, A. Cimmino, L. Scafuri, V. Mirone, O. De Cobelli, S. Shariat, G. Sonpavde, C. Buonerba
Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG
2022 R. Contieri, R. Hurle, M. Paciotti, P. Casale, A. Saita, F. Porpiglia, C. Fiori, B. Barone, F. Crocetto, G. Lucarelli, G.M. Busetto, F. Del Giudice, M. Maggi, F. Cantiello, R. Damiano, M. Borghesi, P. Bove, R. Bertolo, R. Papalia, A. Mari, S. Luzzago, F.A. Mistretta, F. Soria, P. Gontero, M. Marchioni, E. LA Civita, D. Terracciano, G.I. Russo, L. Schips, S. Perdonà, V. Mirone, O.S. Tataru, G. Musi, M.D. Vartolomei, R. Autorino, E. Montanari, O. DE Cobelli, M. Ferro
Active surveillance for prostate cancer: comparison between incidental tumors vs. tumors diagnosed at prostate biopsies
2021 S. Luzzago, M.L. Piccinelli, G. Marvaso, E. Laukhtina, N. Miura, V.M. Schuettfort, K. Mori, A. Aydh, M. Ferro, F.A. Mistretta, N. Fusco, G. Petralia, B.A. Jereczek-Fossa, S.F. Shariat, P.I. Karakiewicz, O. de Cobelli, G. Musi
Acute toxicity of image-guided hypofractionated radiotherapy for prostate cancer: nonrandomized comparison with conventional fractionation
2011 B.A. Jereczek-Fossa, D. Zerini, C. Fodor, L. Santoro, C. Cambria, C. Garibaldi, B. Tagaste, A. Vavassori, F. Cattani, D. Alterio, F. Gherardi, F. Serafini, B. Rocco, G. Musi, O. De Cobelli, R. Orecchia
Adding systematic biopsy to magnetic resonance ultrasound fusion targeted biopsy of the prostate in men with previous negative biopsy or enrolled in active surveillance programs: A prospective single center, randomized study
2020 A. Porreca, F. Del Giudice, M. Giampaoli, D. D'Agostino, D. Romagnoli, P. Corsi, A. Del Rosso, M. Maggi, B.I. Chung, M. Ferro, O. de Cobelli, G. Lucarelli, R. Schiavina, E. De Berardinis, A. Sciarra, G.M. Busetto
Adherence to EAU guidelines on penile cancer translates into better outcomes: a multicenter international study
2018 L. Cindolo, P.E. Spiess, M. Bada, J.J. Chipollini, P. Nyirády, P. Chiodini, J. Varga, P. Ditonno, M. Battaglia, C. De Nunzio, G. Tema, A. Veccia, A. Antonelli, G. Musi, O. De Cobelli, A. Conti, S. Micali, M.A. Maestro, J.Q. Olarte, E. Diogenes, M.V.A. Lima, A. Tracey, G. Guruli, R. Autorino, P. Sountoulides, L. Schips